B

BSIM Therapeutics

4 employees

Small Molecule Therapeutics against Transthyretin-Mediated Amyloidoses

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Transthyretin
Rare Diseases
Pharmaceutical
Lead Optimisation
Drug Discovery
Medicinal Chemistry
hATTR-CM
Therapeutics
Lead Discovery
Amyloidosis
Drug Development
wtATTR
Orphan Drugs
hATTR-PN

Date founded

2011

Funding rounds raised

Total raised

$585K

from 1 investors over 1 rounds

B

BSIM Therapeutics raised $585K on February 13, 2017

Investors: Portugal Ventures

FAQ